Novartis wins temporary pause to Entresto generic launch in US
By Blake Brittain WASHINGTON -A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals’ launch of a generic version of Novartis’ blockbuster heart-failure drug Entresto late on Wednesday. The U.S. Court of Appeals for the District of Columbia Circuit halted the launch, which could have begun as early as Thursday, while it considers Novartis’ emergency request …
Novartis wins temporary pause to Entresto generic launch in US Read More »










